OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SDIS$431.4060

Sdi Group PLC

Advanced Medical Equipment & TechnologyVerified

Sdi Group PLC has a market capitalization of £45.11 billion and a price-to-earnings ratio of 11323.51, indicating a high valuation relative to earnings. The company's price-to-book ratio is 908.78, and its enterprise value to EBITDA is 6511.08, suggesting a premium valuation compared to its book value and earnings before interest, taxes, depreciation, and amortization. The company's liquidity position is characterized by a current ratio of 2.09, indicating it has sufficient current assets to cover its current liabilities. In terms of profitability, Sdi Group PLC has a return on equity of 8.03% and a return on assets of 4.52%, which are below the industry median for the Advanced Medical Equipment & Technology sector. The company's operating margin is 10.47% (calculated from operating income of £6.93 million on revenue of £66.18 million), and its net profit margin is 6.02% (calculated from net income of £3.98 million on revenue of £66.18 million). The company's revenue is derived from three main segments: lab equipment, industrial and scientific sensors, and industrial and scientific products. The lab equipment segment includes businesses such as Safelab Systems and Monmouth Scientific, while the industrial and scientific sensors segment includes Chell Instruments and Astles Control Systems. The geographic exposure is not explicitly detailed in the provided data, but the company's operations are primarily in the United Kingdom. Sdi Group PLC's growth trajectory is reflected in its capital expenditure of -£1.88 million, indicating a reduction in capital spending. The company's free cash flow is £6.33 million, suggesting it has the ability to fund operations and potentially return value to shareholders. The company's revenue for the latest period is £66.18 million, and the outlook for the current fiscal year is not explicitly provided in the data. The risk assessment for Sdi Group PLC indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio is 0.44, and it has a total long-term debt of £21.98 million. The company's net cash position is negative after subtracting total debt, which could impact its liquidity. The company's dilution risk is low, and there are no immediate signs of dilution pressure. Recent events for Sdi Group PLC include analyst estimates with a mean price target of £135.50 and a mean recommendation of 1.50, indicating a generally positive outlook from analysts. The company has one strong-buy recommendation and one buy recommendation, with no hold recommendations.

30-day price · SDIS+17.60 (+27.9%)
Low$63.00High$90.00Close$80.60As of13 May, 00:00 UTC
Profile
CompanySdi Group PLC
TickerSDIS.L
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Sdi Group PLC operates in the healthcare equipment sector, acquiring and developing specialist industrial and scientific products for niche markets including lab equipment, sensors, and scientific instrumentation.

Classification. Sdi Group PLC is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Advanced Medical Equipment & Technology industry with a confidence level of 0.92.

Sdi Group PLC has a market capitalization of £45.11 billion and a price-to-earnings ratio of 11323.51, indicating a high valuation relative to earnings. The company's price-to-book ratio is 908.78, and its enterprise value to EBITDA is 6511.08, suggesting a premium valuation compared to its book value and earnings before interest, taxes, depreciation, and amortization. The company's liquidity position is characterized by a current ratio of 2.09, indicating it has sufficient current assets to cover its current liabilities. In terms of profitability, Sdi Group PLC has a return on equity of 8.03% and a return on assets of 4.52%, which are below the industry median for the Advanced Medical Equipment & Technology sector. The company's operating margin is 10.47% (calculated from operating income of £6.93 million on revenue of £66.18 million), and its net profit margin is 6.02% (calculated from net income of £3.98 million on revenue of £66.18 million). The company's revenue is derived from three main segments: lab equipment, industrial and scientific sensors, and industrial and scientific products. The lab equipment segment includes businesses such as Safelab Systems and Monmouth Scientific, while the industrial and scientific sensors segment includes Chell Instruments and Astles Control Systems. The geographic exposure is not explicitly detailed in the provided data, but the company's operations are primarily in the United Kingdom. Sdi Group PLC's growth trajectory is reflected in its capital expenditure of -£1.88 million, indicating a reduction in capital spending. The company's free cash flow is £6.33 million, suggesting it has the ability to fund operations and potentially return value to shareholders. The company's revenue for the latest period is £66.18 million, and the outlook for the current fiscal year is not explicitly provided in the data. The risk assessment for Sdi Group PLC indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio is 0.44, and it has a total long-term debt of £21.98 million. The company's net cash position is negative after subtracting total debt, which could impact its liquidity. The company's dilution risk is low, and there are no immediate signs of dilution pressure. Recent events for Sdi Group PLC include analyst estimates with a mean price target of £135.50 and a mean recommendation of 1.50, indicating a generally positive outlook from analysts. The company has one strong-buy recommendation and one buy recommendation, with no hold recommendations.
Key takeaways
  • Sdi Group PLC has a high price-to-earnings ratio, indicating a premium valuation relative to earnings.
  • The company's return on equity and return on assets are below the industry median, suggesting lower profitability.
  • The company's capital expenditure is negative, indicating a reduction in capital spending.
  • Sdi Group PLC has a low dilution risk and a medium liquidity risk.
  • Analysts have a generally positive outlook on the company, with a mean price target of £135.50.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue$66.2M
Gross profit$42.9M
Operating income$6.9M
Net income$4.0M
R&D
SG&A
D&A
SBC
Operating cash flow$9.3M
CapEx-$1.9M
Free cash flow$6.3M
Total assets$88.2M
Total liabilities$38.6M
Total equity$49.6M
Cash & equivalents
Long-term debt$22.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$431.40
Market cap$45.11B
Enterprise value$45.13B
P/E11323.5
Reported non-GAAP P/E
EV/Revenue682.0
EV/Op income6511.1
EV/OCF4854.2
P/B908.8
P/Tangible book908.8
Tangible book$49.6M
Net cash-$22.0M
Current ratio2.1
Debt/Equity0.4
ROA4.5%
ROE8.0%
Cash conversion2.3%
CapEx/Revenue-2.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Equipment · cohort 160 companies
MetricSDISActivity
Op margin10.5%-24.0% medp25 -212.9% · p75 6.1%top quartile
Net margin6.0%-20.7% medp25 -188.5% · p75 4.8%top quartile
Gross margin64.9%49.8% medp25 36.6% · p75 67.4%above median
CapEx / revenue-2.8%-4.7% medp25 -11.2% · p75 -1.8%above median
Debt / equity44.0%3.6% medp25 0.0% · p75 22.2%top quartile
Observations
IR observations
Mean price target135.50 GBP
Median price target135.50 GBP
High price target140.00 GBP
Low price target131.00 GBP
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.07 GBP
Last actual EPS0.06 GBP
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 13:56 UTC#a1d3a738
Market quoteclose GBP 431.40 · shares 0.10B diluted
no public URL
2026-05-10 13:56 UTC#3c433a60
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 13:59 UTCJob: 90f874c4